A detailed history of Hollencrest Capital Management transactions in Biomerica Inc stock. As of the latest transaction made, Hollencrest Capital Management holds 11,600 shares of BMRA stock, worth $3,248. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,600
Previous 11,600 -0.0%
Holding current value
$3,248
Previous $5,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$0.42 - $0.86 $516 - $1,057
-1,230 Reduced 9.59%
11,600 $5,000
Q1 2024

May 01, 2024

BUY
$0.82 - $1.29 $3,755 - $5,908
4,580 Added 55.52%
12,830 $10,000
Q4 2023

Feb 14, 2024

BUY
$0.71 - $1.65 $4,011 - $9,322
5,650 Added 217.31%
8,250 $10,000
Q2 2023

Aug 10, 2023

SELL
$1.12 - $1.87 $54,073 - $90,283
-48,280 Reduced 94.89%
2,600 $3,000
Q1 2023

May 16, 2023

BUY
$1.86 - $3.56 $1,636 - $3,132
880 Added 1.76%
50,880 $95,000
Q4 2022

Feb 06, 2023

BUY
$2.98 - $4.17 $149,000 - $208,500
50,000 New
50,000 $167,000

Others Institutions Holding BMRA

About BIOMERICA INC


  • Ticker BMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,427,700
  • Market Cap $3.76M
  • Description
  • Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...
More about BMRA
Track This Portfolio

Track Hollencrest Capital Management Portfolio

Follow Hollencrest Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.